AlanJosephRodneyMD

Breast Cancer, Gastrointestinal Cancer, Hematologic Oncology, Thoracic Cancer

Physician

Dr. Rodney is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Baylor College of MedicineFellowship, Hematology, 2005 - 2006
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2003 - 2006
Louisiana State University School of MedicineResidency, Internal Medicine, 2000 - 2003
Louisiana State University School of Medicine in New OrleansClass of 2000
Xavier University of LouisianaBS, Magna Cum Laude, 1992 - 1996

Best Oncologist - Friendswood and Pearland TX Living Magazine, 2017
Patient�s Choice for Favorite Oncologist Living Magazine, Friendswood and Pearland TX, 2017
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Elsa U. Pardee Foundation Award in Oncology 2005
New Orleans Medical Association Young Physician Award 1998, 2000
Join now to see all

PubMed

37 citations
Survival outcomes for men with mediastinal germ-cell tumors: The University of Texas M. D. Anderson Cancer Center experience
Alan J. Rodney, Nizar M. Tannir, Arlene O. Siefker-Radtke, Ping Liu, Garrett L. Walsh, Randall E. Millikan, Stephen G. Swisher, Shi Ming Tu, Lance C. Pagliaro> ;Urologic Oncology. 2012 Nov 1
8 citations
Choroidal and conjunctival metastases from renal cell carcinoma.
Alan J. Rodney, Dan S. Gombos, Gregory N. Fuller, Lance C. Pagliaro, Nizar M. Tannir> ;American Journal of Clinical Oncology. 2009 Aug 1
4 citations
Ischemic optic neuropathy associated with low-dose interferon alfa: report of two cases.
Alan J. Rodney, Dan S. Gombos, Lance C. Pagliaro, Nizar M. Tannir> ;American Journal of Clinical Oncology. 2009 Feb 1
8 citations
Phase II study of capecitabine combined with gemcitabine in the treatment of androgen-independent prostate cancer previously treated with taxanes.
Alan J. Rodney, Pauline Dieringer, Paul Mathew, Eric Jonasch, Nizar M. Tannir, Lance C. Pagliaro> ;Cancer. 2006 May 15
Join now to see all

Journal Articles

Ischemic Optic Neuropathy Associated with Low Dose Interferon Alfa: Report of Two Cases
A. Rodney, D. Gombos, N. Tannir., American Journal of Clinical Oncology, 1/1/2009
Choroidal and Conjunctival Metastases From Renal Cell Carcinoma
A. J. Rodney, D. S. Gombos, G. N. Fuller, N. M. Tannir, American Journal of Clinical Oncology, 1/1/2009

Abstracts/Posters

Treatment Outcomes of Patients (pts) with Primary Mediastinal Germ Cell Tumors (PMGCT): The M. D. Anderson Cancer Center (MDACC) Experience
A. J. Rodney, A. Siefker-Radtke, N. M. Tannir, S. Swisher, G. Walsh, R. E. Millikan, L. C. Pagliaro, American Society of Clinical Oncology Annual Meeting Proceedings, 1/1/2006
Preliminary Results From a Phase II Study of FOLFIRI Plus Bevacizumab as First-line Treatment for Metastatic Colorectal Cancer (mCRC)
P. M. Hoff MD, C. Eng, R. B. Adinin, R. A. Wolff, E. Lin, S. Kopetz, A. Rodney, D. Z. Chang, J. L. Abbruzzese, American Society of Clinical Oncology Gastrointestinal Cancers Symposium, 1/1/2006
Phase II Study of Capecitabine Combined with Gemcitabine in the Treatment of Androgen-independent Prostate Cancer with Prior Taxane Exposure
A. Rodney, P. Dieringer, P. Mathew, E. Jonasch, N. Tannir, L. Pagliaro., American Society of Clinical Oncology Annual Meeting Proceedings, 1/1/2005